| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |